Spider Rock Advisors, LLC Ptc Therapeutics, Inc. Transaction History
Spider Rock Advisors, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Spider Rock Advisors, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 28,000 shares of PTCT stock, worth $1.14 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
28,000Holding current value
$1.14 Million% of portfolio
0.15%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
271Shares Held
73.1MCall Options Held
180KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$373 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$301 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$259 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$134 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.91B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...